A group of scientists says they will bring back the woolly mammoth by late 2028, and they just announced that they raised ...

Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

CRISPR screening libraries are collections of carefully designed single-guide RNAs (sgRNAs) that allow researchers to ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but ...

Our writer thinks these two speculative shares offer high long-term growth potential from where they currently sit in the ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...